Review



mini-scantm radiotlc linear scanner lablogic systems  (LabLogic Systems Ltd)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    LabLogic Systems Ltd mini-scantm radiotlc linear scanner lablogic systems
    (a, b) Recovery: percentage of [ 89 Zr]Zr-oxine remaining in solution over time when formulated in HEPES buffer only and in presence of 5% EtOHorvarying concentrations of polysorbate 80. Mean ± SDof n = 3 separate experiments. (c) Yield of [ 89 Zr]Zr-oxine over time in HEPES buffers (pH 7.9) containing NaOH ( n = 5) or NaHCO 3 ( n = 4), measured by <t>radioTLC.</t> (d) Stability: [ 89 Zr]Zr-oxine as percentage oftotal 89 Zr activity in solution over 7 days, measured by radioTLC (n = 3), in original 100 pLformulation or after 10-fold dilution with H 2 O. (e) Formation rate and radiochemical yield of [ 89 Zr]Zr-oxine as a function of oxalate content and 89 Zr decay. [ 89 Zr]Zr-oxalate in 1 M oxalic acid (1.1-1.5 MBq/μL on day 0, approximately 4-5 days after production in the cyclotron) was added to 20 μL aliquots of kit formulation on day of reception (day 0) and 4 subsequent days. To keep total 89 Zr activity constant, increasing volumes of [ 89 Zr]Zr-oxalate solution were added on each day, resulting in increasing concentrations of oxalate ions in the final product. Mean ± SD of n = 3 separate experiments.
    Mini Scantm Radiotlc Linear Scanner Lablogic Systems, supplied by LabLogic Systems Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/radiotlc+linear+scanner+lablogic+mini-scantm/mini+scantm+radiotlc+linear+scanner+lablogic+systems/pmc07116765-56-6-10
    Average 90 stars, based on 1 article reviews
    mini-scantm radiotlc linear scanner lablogic systems - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "A kit formulation for the preparation of [ 89 Zr]Zr(oxinate) 4 for PET cell tracking: White blood cell labelling and comparison with [ 111 In]In(oxinate) 3"

    Article Title: A kit formulation for the preparation of [ 89 Zr]Zr(oxinate) 4 for PET cell tracking: White blood cell labelling and comparison with [ 111 In]In(oxinate) 3

    Journal: Nuclear medicine and biology

    doi: 10.1016/j.nucmedbio.2020.09.002

    (a, b) Recovery: percentage of [ 89 Zr]Zr-oxine remaining in solution over time when formulated in HEPES buffer only and in presence of 5% EtOHorvarying concentrations of polysorbate 80. Mean ± SDof n = 3 separate experiments. (c) Yield of [ 89 Zr]Zr-oxine over time in HEPES buffers (pH 7.9) containing NaOH ( n = 5) or NaHCO 3 ( n = 4), measured by radioTLC. (d) Stability: [ 89 Zr]Zr-oxine as percentage oftotal 89 Zr activity in solution over 7 days, measured by radioTLC (n = 3), in original 100 pLformulation or after 10-fold dilution with H 2 O. (e) Formation rate and radiochemical yield of [ 89 Zr]Zr-oxine as a function of oxalate content and 89 Zr decay. [ 89 Zr]Zr-oxalate in 1 M oxalic acid (1.1-1.5 MBq/μL on day 0, approximately 4-5 days after production in the cyclotron) was added to 20 μL aliquots of kit formulation on day of reception (day 0) and 4 subsequent days. To keep total 89 Zr activity constant, increasing volumes of [ 89 Zr]Zr-oxalate solution were added on each day, resulting in increasing concentrations of oxalate ions in the final product. Mean ± SD of n = 3 separate experiments.
    Figure Legend Snippet: (a, b) Recovery: percentage of [ 89 Zr]Zr-oxine remaining in solution over time when formulated in HEPES buffer only and in presence of 5% EtOHorvarying concentrations of polysorbate 80. Mean ± SDof n = 3 separate experiments. (c) Yield of [ 89 Zr]Zr-oxine over time in HEPES buffers (pH 7.9) containing NaOH ( n = 5) or NaHCO 3 ( n = 4), measured by radioTLC. (d) Stability: [ 89 Zr]Zr-oxine as percentage oftotal 89 Zr activity in solution over 7 days, measured by radioTLC (n = 3), in original 100 pLformulation or after 10-fold dilution with H 2 O. (e) Formation rate and radiochemical yield of [ 89 Zr]Zr-oxine as a function of oxalate content and 89 Zr decay. [ 89 Zr]Zr-oxalate in 1 M oxalic acid (1.1-1.5 MBq/μL on day 0, approximately 4-5 days after production in the cyclotron) was added to 20 μL aliquots of kit formulation on day of reception (day 0) and 4 subsequent days. To keep total 89 Zr activity constant, increasing volumes of [ 89 Zr]Zr-oxalate solution were added on each day, resulting in increasing concentrations of oxalate ions in the final product. Mean ± SD of n = 3 separate experiments.

    Techniques Used: Activity Assay, Formulation

    Related Articles

    Thin Layer Chromatography:

    Article Title: [ 18 F]tetrafluoroborate as a PET tracer for the sodium/iodide symporter: the importance of specific activity
    Article Snippet: RadioTLC was carried out using a neutral alumina stationary phase (Macherey-Nagel, 10 × 80 mm, Polygram ALOX N/UV 254 ) with methanol (100 %) as the mobile phase. .. The thin-layer chromatography (TLC) plates were scanned using a radioTLC linear scanner (LabLogic Mini-ScanTM) with β + probe (LabLogic B-FC-3600). ..



    Similar Products

    90
    LabLogic Systems Ltd mini-scantm radiotlc linear scanner lablogic systems
    (a, b) Recovery: percentage of [ 89 Zr]Zr-oxine remaining in solution over time when formulated in HEPES buffer only and in presence of 5% EtOHorvarying concentrations of polysorbate 80. Mean ± SDof n = 3 separate experiments. (c) Yield of [ 89 Zr]Zr-oxine over time in HEPES buffers (pH 7.9) containing NaOH ( n = 5) or NaHCO 3 ( n = 4), measured by <t>radioTLC.</t> (d) Stability: [ 89 Zr]Zr-oxine as percentage oftotal 89 Zr activity in solution over 7 days, measured by radioTLC (n = 3), in original 100 pLformulation or after 10-fold dilution with H 2 O. (e) Formation rate and radiochemical yield of [ 89 Zr]Zr-oxine as a function of oxalate content and 89 Zr decay. [ 89 Zr]Zr-oxalate in 1 M oxalic acid (1.1-1.5 MBq/μL on day 0, approximately 4-5 days after production in the cyclotron) was added to 20 μL aliquots of kit formulation on day of reception (day 0) and 4 subsequent days. To keep total 89 Zr activity constant, increasing volumes of [ 89 Zr]Zr-oxalate solution were added on each day, resulting in increasing concentrations of oxalate ions in the final product. Mean ± SD of n = 3 separate experiments.
    Mini Scantm Radiotlc Linear Scanner Lablogic Systems, supplied by LabLogic Systems Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/radiotlc+linear+scanner+lablogic+mini-scantm/mini+scantm+radiotlc+linear+scanner+lablogic+systems/pmc07116765-56-6-10
    Average 90 stars, based on 1 article reviews
    mini-scantm radiotlc linear scanner lablogic systems - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    LabLogic Systems Ltd radiotlc linear scanner lablogic mini-scantm
    (a, b) Recovery: percentage of [ 89 Zr]Zr-oxine remaining in solution over time when formulated in HEPES buffer only and in presence of 5% EtOHorvarying concentrations of polysorbate 80. Mean ± SDof n = 3 separate experiments. (c) Yield of [ 89 Zr]Zr-oxine over time in HEPES buffers (pH 7.9) containing NaOH ( n = 5) or NaHCO 3 ( n = 4), measured by <t>radioTLC.</t> (d) Stability: [ 89 Zr]Zr-oxine as percentage oftotal 89 Zr activity in solution over 7 days, measured by radioTLC (n = 3), in original 100 pLformulation or after 10-fold dilution with H 2 O. (e) Formation rate and radiochemical yield of [ 89 Zr]Zr-oxine as a function of oxalate content and 89 Zr decay. [ 89 Zr]Zr-oxalate in 1 M oxalic acid (1.1-1.5 MBq/μL on day 0, approximately 4-5 days after production in the cyclotron) was added to 20 μL aliquots of kit formulation on day of reception (day 0) and 4 subsequent days. To keep total 89 Zr activity constant, increasing volumes of [ 89 Zr]Zr-oxalate solution were added on each day, resulting in increasing concentrations of oxalate ions in the final product. Mean ± SD of n = 3 separate experiments.
    Radiotlc Linear Scanner Lablogic Mini Scantm, supplied by LabLogic Systems Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/radiotlc+linear+scanner+lablogic+mini-scantm/mini+scantm+radiotlc+linear+scanner+lablogic+systems/pmc04840125-48-9-12
    Average 90 stars, based on 1 article reviews
    radiotlc linear scanner lablogic mini-scantm - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    (a, b) Recovery: percentage of [ 89 Zr]Zr-oxine remaining in solution over time when formulated in HEPES buffer only and in presence of 5% EtOHorvarying concentrations of polysorbate 80. Mean ± SDof n = 3 separate experiments. (c) Yield of [ 89 Zr]Zr-oxine over time in HEPES buffers (pH 7.9) containing NaOH ( n = 5) or NaHCO 3 ( n = 4), measured by radioTLC. (d) Stability: [ 89 Zr]Zr-oxine as percentage oftotal 89 Zr activity in solution over 7 days, measured by radioTLC (n = 3), in original 100 pLformulation or after 10-fold dilution with H 2 O. (e) Formation rate and radiochemical yield of [ 89 Zr]Zr-oxine as a function of oxalate content and 89 Zr decay. [ 89 Zr]Zr-oxalate in 1 M oxalic acid (1.1-1.5 MBq/μL on day 0, approximately 4-5 days after production in the cyclotron) was added to 20 μL aliquots of kit formulation on day of reception (day 0) and 4 subsequent days. To keep total 89 Zr activity constant, increasing volumes of [ 89 Zr]Zr-oxalate solution were added on each day, resulting in increasing concentrations of oxalate ions in the final product. Mean ± SD of n = 3 separate experiments.

    Journal: Nuclear medicine and biology

    Article Title: A kit formulation for the preparation of [ 89 Zr]Zr(oxinate) 4 for PET cell tracking: White blood cell labelling and comparison with [ 111 In]In(oxinate) 3

    doi: 10.1016/j.nucmedbio.2020.09.002

    Figure Lengend Snippet: (a, b) Recovery: percentage of [ 89 Zr]Zr-oxine remaining in solution over time when formulated in HEPES buffer only and in presence of 5% EtOHorvarying concentrations of polysorbate 80. Mean ± SDof n = 3 separate experiments. (c) Yield of [ 89 Zr]Zr-oxine over time in HEPES buffers (pH 7.9) containing NaOH ( n = 5) or NaHCO 3 ( n = 4), measured by radioTLC. (d) Stability: [ 89 Zr]Zr-oxine as percentage oftotal 89 Zr activity in solution over 7 days, measured by radioTLC (n = 3), in original 100 pLformulation or after 10-fold dilution with H 2 O. (e) Formation rate and radiochemical yield of [ 89 Zr]Zr-oxine as a function of oxalate content and 89 Zr decay. [ 89 Zr]Zr-oxalate in 1 M oxalic acid (1.1-1.5 MBq/μL on day 0, approximately 4-5 days after production in the cyclotron) was added to 20 μL aliquots of kit formulation on day of reception (day 0) and 4 subsequent days. To keep total 89 Zr activity constant, increasing volumes of [ 89 Zr]Zr-oxalate solution were added on each day, resulting in increasing concentrations of oxalate ions in the final product. Mean ± SD of n = 3 separate experiments.

    Article Snippet: ITLC plates were read using a Mini-ScanTM radioTLC linear scanner (LabLogic Systems) equipped with a β + probe (LabLogic B-FC-3600).

    Techniques: Activity Assay, Formulation